ASNS and acute myeloid leukemia: Early studies have shown that upregulated expression of ASNS could be related to the resistance of leukemia cells to L-aspartase, which is widely used as an active component in the treatment of pediatric acute lymphocytic leukaemia and some types of acute myeloid leukaemia (Zwaan et al., 2002).